JEPI240816C57000
- 0.30
- -0.12-28.57%
JPMorgan Equity Premium Income ETF Newsroom
Alphabet Price Target Raised to $210.00/Share From $195.00 by Morgan Stanley
Amazon Price Target Raised to $240.00/Share From $220.00 by Morgan Stanley
Alphabet Analyst Ratings
Amazon.com Analyst Ratings
Vertex Pharmaceuticals Analyst Ratings
Stifel Maintains Alphabet-A(GOOGL.US) With Buy Rating, Maintains Target Price $196
Morgan Stanley Maintains Alphabet-A(GOOGL.US) With Buy Rating, Raises Target Price to $210
A Quick Look at Today's Ratings for Alphabet-A(GOOGL.US), With a Forecast Between $196 to $225
Jefferies Maintains Meta Platforms(META.US) With Buy Rating, Raises Target Price to $565
Morgan Stanley Adjusts Price Target on Southern to $72 From $71, Maintains Equalweight Rating
Morgan Stanley Maintains Amazon(AMZN.US) With Buy Rating, Raises Target Price to $240
Piper Sandler Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Raises Target Price to $500
TD Cowen Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Raises Target Price to $500
TD Cowen Adjusts Price Target on Vertex Pharmaceuticals to $500 From $450, Maintains Buy Rating
Buy Rating Affirmed for Vertex Pharmaceuticals Amid Strategic Acquisition and Strong CF Franchise Outlook
Alphabet Price Target Maintained With a $210.00/Share by Needham
Piper Sandler Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)
Morgan Stanley Adjusts Price Target on Amazon.com to $240 From $220, Maintains Overweight Rating
Morgan Stanley Adjusts Price Target on Alphabet to $210 From $195, Maintains Overweight Rating
Microsoft Analyst Ratings